Home » Topics » Regulatory » Patents

Patents
RSS

AstraZeneca patents FLAP and leukotriene synthesis inhibitors

Nov. 25, 2016

Pfizer describes JAK inhibitors

Nov. 24, 2016

Genentech and Roche disclose retinoid RORgamma receptor ligands

Nov. 24, 2016

Pfizer patents myeloperoxidase irreversible inhibitors

Nov. 24, 2016

Bayer Healthcare divulges TNKS1/TNKS2 inhibitors for cancer

Nov. 23, 2016

Chiesi Farmaceutici reports compounds for asthma and COPD

Nov. 23, 2016

AstraZeneca describes LTC4 synthase inhibitors

Nov. 23, 2016

University of Colorado patent reveals beta-lactam antibiotic sensitizers

Nov. 23, 2016

Rgenix patents SLC6A8 inhibitors for cancer

Nov. 23, 2016

Roche presents HBsAg and HBV DNA production inhibitors

Nov. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...